Science and Research committee  I think so, for sure. That makes a lot of sense, actually. My son is a scientist as well. He works with farmers all the time in trying to understand different aspects of it. I think that's totally a viable pathway forward, for sure.

Science and Research committee  I think what we're all talking about is trying to find ways to create more cohesive research programs that will advance these sorts of new discoveries faster. That's certainly one of the objectives of BioCanRx, but also of the neuroscience networks: that is, trying to find ways t

Science and Research committee  You're absolutely right. The earlier the detection, the better. Everybody knows that's the case. For some cancers that's fairly straightforward to do, but for many, as you say, they are silent. We don't know the answer. What's happening is that people are starting to use—back to

Science and Research committee  Potentially, I think, to your point.... It's complex, obviously. Our diets are very complex, so using something like artificial intelligence, which has the computing power to begin to deconvolute these things, potentially could be used in a larger population study to say that thi

Science and Research committee  Maybe I'll respond. In line with what Guy was just saying about the different models and new approaches, we believe it is a new approach for science, not only in discovery, as Guy was referring to, but also in translation. Rather than fill the coffers of companies, we feel a bett

Science and Research committee  Just to add to that, in California now, again using the CAR T-cell approach in this particular indication, they are seeing some promising activity in young kids suffering from it. I think there are things happening, as Guy mentioned, and I think there are a lot of new opportunit

Science and Research committee  I hate to admit it, but we'd be nowhere. I mean, we need the isotopes for imaging. Many kinds of therapies that are effective for cancer, especially if the disease is localized, require radioisotopes. I think the challenge in cancer, though, is that for most patients who come to

Science and Research committee  As I am sure you can appreciate from the work your committee has already done to date, the hallmarks of a successful moon shot program include building cross-disciplinary teams of thought leaders, creating a nimble, independent decision-making body that manages a portfolio of inn

Science and Research committee  That's a great question, and great points, actually. The reality is that when you manufacture in a particular country, you don't want to move your manufacturing plant. You want to keep it there for the duration of the product's lifetime because it costs a lot of money to move it

Science and Research committee  It's again the right question to ask because these are incredible new therapies and, in many cases, are providing people a very long or extended lifespan, if not a cure. As you point out, right now in the case of CAR-T, for instance, when we send a patient to Pennsylvania or to S

Science and Research committee  That's our dream, of course, and the way we do that is to work with companies in Canada like Allen's company—that kind of company that's here in Canada—so that we can help facilitate those phase 1, phase 2, phase 3 studies here, and get it approved in Canada. Also during that who

Science and Research committee  We've talked about that. I think there is certainly value in that from the kinds of things we're doing to make sure that we have a pricing system that will work for Canadians and the Canadian health care system. And congratulations on your 40th birthday too.

Science and Research committee  Let me just give you an example. This actually already exists to some extent in our hospitals. We do bone marrow transplants, which I assume everybody has heard about. In fact Allen's company does a lot of products to support that kind of activity. Bone marrow transplants are do

Science and Research committee  It's a great question. Sure, I'm happy to answer that. I think it is an important question. What BioCanRx is concerned about is that our IP will go outside the country and be developed elsewhere. Right now if an academic scientist should develop an invention, it belongs to that

Science and Research committee  Stéphanie may have some thoughts about that, but I don't think I can really comment. I don't know enough about the PMPRB program to actually weigh in on that, to be honest. Stéphanie, do you have any thoughts on it?